Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Radiopharma Berlin is a specialized radiopharmaceutical company based in Germany, operating as a subsidiary of Eckert & Ziegler. The company focuses on the production and distribution of radiopharmaceuticals used in positron emission tomography (PET) and other nuclear medicine applications. Its core business includes the contract manufacturing of diagnostic and therapeutic radioisotopes, such as Gallium-68 and Lutetium-177 labeled compounds. Life Radiopharma Berlin provides essential infrastructure for the clinical supply of tracers used in oncology, particularly for prostate cancer and neuroendocrine tumor imaging. By leveraging its GMP-certified facilities, the company supports both routine clinical care and pharmaceutical development through its CDMO services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Life Radiopharma Berlin.